ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
Metrics to compare | ZIML | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZIMLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 46.7x | 29.0x | −0.5x | |
PEG Ratio | −0.86 | 0.23 | 0.00 | |
Price/Book | 1.3x | 3.2x | 2.6x | |
Price / LTM Sales | 0.9x | 2.5x | 3.2x | |
Upside (Analyst Target) | - | 26.8% | 45.2% | |
Fair Value Upside | Unlock | 2.1% | 6.4% | Unlock |